fig6

Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance

Figure 6. DOX solution, DOX-NPs, and GC DOX-NPs were incubated with A2780res and EMT6/AR10 cells for 24 h (A, C) and 48 h (B) and the cell viability was evaluated. Each bar represents the mean ± SD of five different experiments (n = 3). DOX: doxorubicin hydrochloride; GC: glycol chitosan-coated; DOX-NPs: DOX-loaded nanoparticles

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/